Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

11084	Companies
243306	Keywords
171464	Articles
131025	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 12/05/2024 at 18:00, 1 year 9 months ago

Article about Canalevia-CA1, Jaguar Health's Prescription Drug Conditionally Approved by the FDA for the Treatment of Chemotherapy-Induced Diarrhea in Dogs, Published in PetVet Magazine
Jaguar Health announces Canalevia-CA1, a canine-specific crofelemer drug for chemotherapy-induced diarrhea in dogs with FDA approval, detailed safety information provided

Crofelemer FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea
BRIEF

published on 12/02/2024 at 16:05, 1 year 9 months ago

Jaguar Health Seeks Partner for Canine Diarrhea Drug at Pet Connect Conference

FDA Approval Jaguar Health Canine Diarrhea Pet Connect Conference NP300 Development
BRIEF

published on 12/02/2024 at 16:05, 1 year 9 months ago

Jaguar Health recherche un partenaire pour un médicament contre la diarrhée canine lors de la conférence Pet Connect

Approbation De La FDA Santé Jaguar Diarrhée Canine Conférence Pet Connect Développement Du NP300
PRESS RELEASE

published on 12/02/2024 at 16:00, 1 year 9 months ago

Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Jaguar Health Inc. announces extension of conditional approval by FDA for Canalevia®-CA1 drug for chemotherapy-induced diarrhea in dogs and seeks partners for NP300 prescription drug for general diarrhea in dogs at Pet Connect conference

FDA Approval Canalevia-CA1 Jaguar Health Inc. NP300 Pet Connect Conference
BRIEF

published on 11/25/2024 at 16:05, 1 year 10 months ago

Jaguar Health to Present at Two Upcoming Conferences

Pharmaceuticals Jaguar Health Lisa Conte Conference Presentation Gastrointestinal Medicine
BRIEF

published on 11/25/2024 at 16:05, 1 year 10 months ago

Jaguar Health participera à deux conférences à venir

Lisa Conte Médicaments Santé Jaguar Présentation De La Conférence Médecine Gastro-intestinale
PRESS RELEASE

published on 11/25/2024 at 16:00, 1 year 10 months ago

Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference
Jaguar Health, Inc. to present at NobleCon20 and Emerging Growth Conference. Lisa Conte to present on December 3 and virtually on December 5, 2024. Jaguar focuses on gastrointestinal distress medicines

Pharmaceuticals Jaguar Health Lisa Conte Emerging Growth Conference NobleCon20
BRIEF

published on 11/22/2024 at 14:50, 1 year 10 months ago

Jaguar Health Seeks Partner for Dog Diarrhea Drug NP300

FDA Approval Jaguar Health NP300 Dog Diarrhea Pet Connect Conference
BRIEF

published on 11/22/2024 at 14:50, 1 year 10 months ago

Jaguar Health recherche un partenaire pour le médicament NP300 contre la diarrhée canine

Approbation De La FDA Santé Jaguar NP300 Diarrhée Du Chien Conférence Pet Connect
PRESS RELEASE

published on 11/22/2024 at 14:45, 1 year 10 months ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Jaguar Health, Inc. announces extension of FDA approval for Canalevia®-CA1 for chemotherapy-induced diarrhea in dogs, seeks partner for NP300 development at Pet Connect conference

Jaguar Health Diarrhea Veterinary NP300 Canalevia®-CA1

Accesswire

Published on 09/26/2026 at 01:00, 2 days 4 hours ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 2 days 4 hours ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 7 hours ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 11 hours ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 14 hours ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

EQS Group

Published on 09/27/2026 at 17:05, 12 hours 12 minutes ago

Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 13 hours ago

QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 13 hours ago

QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 14 hours ago

Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 21 hours ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe

Les Echos

Published on 09/26/2026 at 07:00, 1 day 22 hours ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 2 days 11 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 2 days 11 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 2 days 11 hours ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 11 hours ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE